BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8136262)

  • 1. Plant-Derived Type I Ribosome Inactivating Protein-Based Targeted Toxins: A Review of the Clinical Experience.
    Flavell DJ; Flavell SU
    Toxins (Basel); 2022 Aug; 14(8):. PubMed ID: 36006226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group.
    Meany HJ; Seibel NL; Krailo M; Villaluna D; Chen Z; Gaynon P; Neglia JP; Park JR; Hutchinson R; Sato JK; Wells RJ; Woods WG; Reaman G
    J Immunother; 2015 Sep; 38(7):299-305. PubMed ID: 26261894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.
    Gilabert-Oriol R; Weng A; Mallinckrodt Bv; Melzig MF; Fuchs H; Thakur M
    Curr Pharm Des; 2014; 20(42):6584-643. PubMed ID: 25341935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotoxins: a review of their use in cancer treatment.
    Aruna G
    J Stem Cells Regen Med; 2006; 1(1):31-6. PubMed ID: 24692859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxin-based therapeutic approaches.
    Shapira A; Benhar I
    Toxins (Basel); 2010 Nov; 2(11):2519-83. PubMed ID: 22069564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotoxins for targeted cancer therapy.
    Kreitman RJ
    AAPS J; 2006 Aug; 8(3):E532-51. PubMed ID: 17025272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of pokeweed antiviral protein mutations in Saccharomyces cerevisiae: evidence that ribosome depurination is not sufficient for cytotoxicity.
    Hudak KA; Parikh BA; Di R; Baricevic M; Santana M; Seskar M; Tumer NE
    Nucleic Acids Res; 2004; 32(14):4244-56. PubMed ID: 15304562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotoxins for the treatment of B-cell lymphomas.
    Ghetie MA; Ghetie V; Vitetta ES
    Mol Med; 1997 Jul; 3(7):420-7. PubMed ID: 9260154
    [No Abstract]   [Full Text] [Related]  

  • 9. Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.
    Flavell DJ; Flavell SU; Boehm DA; Emery L; Noss A; Ling NR; Richardson PR; Hardie D; Wright DH
    Br J Cancer; 1995 Dec; 72(6):1373-9. PubMed ID: 8519647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-associated CD19-LYN complex is an endogenous p53-independent and Bc1-2-independent regulator of apoptosis in human B-lineage lymphoma cells.
    Myers DE; Jun X; Waddick KG; Forsyth C; Chelstrom LM; Gunther RL; Tumer NE; Bolen J; Uckun FM
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9575-9. PubMed ID: 7568175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical engineering of immunotoxins for ex vivo bone marrow transplantation and in vivo leukemia treatment.
    Carayon P; Casellas P; Jansen FK
    Targeted Diagn Ther; 1989; 2():41-52. PubMed ID: 2519549
    [No Abstract]   [Full Text] [Related]  

  • 12. New method for treatment of leukaemia.
    Indian J Med Sci; 2000 Aug; 54(8):357. PubMed ID: 11143754
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of graft-versus-host disease by using immunotoxins.
    Laurent G; Bouloux C
    Prog Clin Biol Res; 1992; 377():129-36; discussion 137. PubMed ID: 1438408
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotoxins for the treatment of leukaemia.
    Uckun FM
    Br J Haematol; 1993 Nov; 85(3):435-8. PubMed ID: 8136262
    [No Abstract]   [Full Text] [Related]  

  • 15. Allograft and autograft purging using immunotoxins in clinical bone marrow transplantation for hematologic malignancies.
    Uckun FM; Myers DE
    J Hematother; 1993; 2(2):155-63. PubMed ID: 7921971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunological treatment of human marrow in vitro in transplantation biology.
    Gribben JG; Nadler LM
    Cancer Treat Res; 1993; 64():189-211. PubMed ID: 8095793
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.